NSCLC Treatment Gets Specific with Next-Gen Sequencing, Cell-Free DNA

During a presentation on advanced non-small cell lung cancer (NSCLC), Ben Levy, M.D., a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, said there is a new opportunity for clinicians to be more specific when targeting mutations in those cancer patients. […]

⋅ , , , , ⋅

Benefits of Immunotherapy in Metastatic Non-Small Cell Lung Cancer

Julie Brahmer, M.D., is an active clinical leader in the treatment of lung cancer and mesothelioma. As the director of the Thoracic Oncology Program and professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, her research and clinical practice focuses on the development of new therapies for the treatment and prevention […]

⋅ , , , , , , ⋅